Selma Ugurel

28PUBLICATIONS
126CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyEpidemiological methodsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Oct 23, 2026
Extracorporeal photopheresis for the treatment of steroid-refractory immune related adverse events from immune checkpoint inhibitor therapy: a multi-center phase Ib/II clinical trial.

|Feb 20, 2026
Melanoma of unknown primary shows an oncogenic pattern and clinical course of sun-exposed melanoma.

Georg Lodde, Jonida Dollani, Wolfgang Galetzka

|Oct 23, 2025
High-resolution spatial transcriptomics uncover epidermal-dermal divergences in Merkel cell carcinoma: spatial context reshapes the gene expression landscape.

Kuan Cheok Lei, Nalini Srinivas, Mitalee Chandra

|Sep 24, 2025
Tertiary lymphoid structures in Merkel cell carcinoma facilitate naïve and central memory T-cell infiltration linked to immunotherapy response.

Nalini Srinivas, Ivelina Spassova, Kuan Cheok Lei

|Jun 03, 2025
Long-Term Follow-Up of Real-World Adjuvant Anti-PD-1 Checkpoint Inhibition and Targeted Therapy in Patients With Stage III Melanoma.

Georg C Lodde, Jessica C Hassel, Imke von Wasielewski

|Dec 31, 2024
Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanoma.

Jan-Malte Placke, Jenny Bottek, Renata Váraljai

Pageof 5

Frequent Collaborators

10 joint publications

Michael Weichenthal

9 joint publications

Dirk Schadendorf

8 joint publications

Jürgen Christian Becker

6 joint publications

Elisabeth Livingstone